Fig. 2From: Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trialsThe results of the risk of bias assessment. A Stacked bar chart showing a summary of the risk of bias assessment overall and in each domain. B The detailed answers for all studies in each domainBack to article page